Horizon therapeutics sec filings
Web9 jan. 2024 · Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. Here you'll find links to a complete list of filings available through EDGAR and instructions for searching the … Web13 apr. 2024 · A high-level overview of Horizon Therapeutics Public Limited Company (HZNP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Horizon therapeutics sec filings
Did you know?
WebSEC Filing HTML 0001193125-22-302832 Horizon Therapeutics plc UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14 (a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate … Web14 apr. 2024 · Horizon Therapeutics Public Stock Performance. Shares of NASDAQ:HZNP opened at $110.72 on Friday. The company has a market capitalization of $25.29 billion, a price-to-earnings ratio of 49.65, a P ...
WebHorizon Pharma, Inc., a biopharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.Whalewisdom has at least 227 Form 4 filings The firm last ... Web14 apr. 2024 · DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the Indications and Usage section of the TEPEZZA label to specify its use for the treatment of “Thyroid Eye Disease regardless of Thyroid Eye Disease activity or …
Web17 dec. 2024 · Takeda will provide a hard copy of its latest Annual Report on Form 20-F, which includes its most recent complete audited financial statements, free of charge to any securityholder upon request. Securityholders should contact Takeda Investor Relations by e-mail at [email protected] to request a hard copy. ・Other SEC Documents ... Web23 dec. 2024 · Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients.
Web11 apr. 2024 · The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Andy Pasternak sold 27,129 shares of Horizon Therapeutics Public stock in a transaction on Tuesday, January 17th. The stock was sold at an average price of $113.03, for a total value of …
Web14 mrt. 2024 · 4. STONE JOHN H. Statement of Changes in Beneficial Ownership. 02/28/2024. DOC XLS PDF XBRL. 4. PRECZEWSKI JENNIFER L. Statement of Changes in Beneficial Ownership. 02/28/2024. movies and tv onlineWebSECURITIES AND EXCHANGE COMMISSION . Washington, D.C. 20549 . SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the . Securities Exchange Act of 1934 ... HORIZON THERAPEUTICS PLC . by . Pillartree Limited, a newly formed private limited company wholly owned by Amgen Inc. movies and tv shortcutsWeb2 dec. 2024 · Latest SEC filings for Horizon Therapeutics (HZNP). Loading. Advanced. What's new? Log in Free sign up. Home; Sectors & Industries Sectors; ... Export a CSV file of filings or unique filing companies ... Horizon Therapeutics plc Reports Fourth-Quarter and Full-Year 2024 Financial Results. heather overbyWebView: Download DOC. Download PDF heather overlandWebPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): February 24, 2024 Horizon Therapeutics Public Limited Company (Exact name of registrant as specified in its charter) ... heather outsideWeb14 apr. 2024 · -- Updated indication language reinforces the importance of unrestricted access for patients across full spectrum of Thyroid Eye Disease --DUBLIN--(BUSINESS WIRE)--Apr. 14, 2024-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the Indications … heather overly smith obituaryWebSEC Filings Amgen Inc. Skip to main navigation Main Menu About Overview Amgen History Mission and Values Leadership Awards and Accolades How We Operate Overview Corporate Governance Business Ethics and Compliance Policies, Practices and Disclosures Science Overview heather overly